Pyridostigmine Bromide Tablet, Extended Release
Product Images NDC 47781-335

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 47781-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Bottle Label)

Label for Pyridostigmine Bromide 180 mg extended-release tablets by Alvogen, Inc. The label includes tablet images embossed with '335', dosage strength, and warnings about moisture sensitivity. It states 'Rx only' and a quantity of 30 tablets. Storage instructions and barcodes are also visible.*

FDA Label Image

Structure (Structure)

Chemical structure of Pyridostigmine Bromide, illustrating the molecular arrangement including a pyridine ring with a quaternary nitrogen, methyl groups, and bromide ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.